                         SEQUENCE LISTING

<110>  The Regents of the University of California
       Spector, Deborah H.
       Morello, Christopher S.
       Kraynyak, Kimberly A.
 
<120>  Herpes Virus Vaccine and Methods of Use

<130>  88654-006710PC-844147

<150>  US 61/503,945
<151>  2011-07-01

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  1
gccaccatgg cggcgtccgg cggggag                                           27


<210>  2
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  2
atagacaatg accacattcg gatcgcgtag agc                                    33


<210>  3
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  3
gccaccatgt tttgtgccgc gggcggc                                           27


<210>  4
<211>  36
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  4
tgctagagta tcaaaggctc tatgcaacat tcgacg                                 36


<210>  5
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  5
gccaccatgg ggcgtttgac ctcc                                              24


<210>  6
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  6
gacgtcctgg atcgacgg                                                     18


<210>  7
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  7
gccaccatgg ctaccgacat tgatatg                                           27


<210>  8
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  8
aaatagggag ttgcagtaga agtatttgcc gtg                                    33


<210>  9
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  9
gccagatata cgccatgaca ttgattattg                                        30


<210>  10
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  10
caataatcaa tgtcatggcg tatatctggc                                        30


<210>  11
<211>  74
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  11
ggtaccgagc tcggatccac gtcgactaca aggatgacga tgacaagtga taatagtcca       60

gtgtggtgga attc                                                         74


<210>  12
<211>  74
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  12
gaattccacc acactggact attatcactt gtcatcgtca tccttgtagt cgacgtggat       60

ccgagctcgg tacc                                                         74


<210>  13
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide.

<400>  13

His Gly Pro Ser Leu Tyr Arg Thr Phe 
1               5                   


<210>  14
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  14
tgtggcaatg gcaaaaagc                                                    19


<210>  15
<211>  25
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.

<400>  15
tgttaccatt tgtgatgttt tcgat                                             25


<210>  16
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer.


<220>
<221>  modified_base
<222>  (1)..(1)
<223>  5' c modified with cgtctatac oligonucleotide modified at 5' c 
       with 6-FAM oligonucleotide and linked through Zen(TM) linker.

<220>
<221>  modified_base
<222>  (20)..(20)
<223>  3' a modified with Iowa Black F Quencher

<400>  16
ccgagtgtca tcctaccgga                                                   20


